DTaP
Sponsors
Novartis Vaccines, Pfizer, Merck Sharp & Dohme LLC, Duke University, China National Biotec Group Company Limited
Conditions
ApneaApnea NeonatalDiphteria, Tetanus and PertussisFebrile SeizureFeverFever After VaccinationHealthy SubjectsMMR Vaccine
Phase 3
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants
CompletedNCT00474526
Start: 2007-03-31End: 2009-11-30Updated: 2014-03-24
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants
CompletedNCT01200368
Start: 2010-09-24End: 2011-11-30Updated: 2018-12-19
Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
CompletedNCT02062385
Start: 2014-05-30End: 2015-06-11Updated: 2018-11-27
Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial
RecruitingNCT07112144
Start: 2025-06-13End: 2032-06-30Target: 1650Updated: 2025-08-08
Phase 4
A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.
CompletedNCT01250756
Start: 2010-11-30End: 2012-03-31Updated: 2013-02-26
Fever After Simultaneous Versus Sequential Vaccination in Young Children
CompletedNCT03165981
Start: 2017-08-25End: 2018-01-15Updated: 2024-11-18
Apnea in Hospitalized Preterm Infants Following the Administration of Routine Childhood Vaccines
CompletedNCT03530124
Start: 2018-07-17End: 2021-11-01Updated: 2024-02-14
Clinic Trial to Evaluate the Safety and Immunogenicity of Combined Immunization of sIPV and DTaP
NCT04053010
Start: 2019-08-10End: 2020-05-30Target: 702Updated: 2019-08-12
Evaluation of the Safety and Immunogenicity of Simultaneously Administration of sIPV and DTaP
CompletedNCT04054882
Start: 2019-08-16End: 2021-09-09Updated: 2022-07-07
Evaluation of Safety and Immunogenicity of Combined Immunization of sIPV, DTaP and HepA
NCT04636827
Start: 2020-11-11End: 2021-12-31Target: 600Updated: 2020-11-19
Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR
NCT04638985
Start: 2020-11-13End: 2021-12-31Target: 600Updated: 2020-12-10
Study of Concomitant Administration of the sIPV and DTaP or MMR
Not yet recruitingNCT06920069
Start: 2025-05-15End: 2031-06-15Target: 2640Updated: 2025-04-17